by S Joshi 2024Low-dose methylprednisolone had comparable outcomes including mortality to high-dose methylprednisolone for the treatment of severe COVID-19.
Presented: This was presented as an oral presentation at 23rd International methylprednisolone high dose for Covid-19 pneumonia. PLoS One. 2024;16
by S Joshi 2024Low-dose methylprednisolone had comparable outcomes including mortality to high-dose methylprednisolone for the treatment of severe COVID-19.
oral, for. up to seven days. LDC was defined as methylprednisolone 40 mg methylprednisolone high dose for Covid-19 pneumonia. Article. Full-text available.
by S Joshi 2024Low-dose methylprednisolone had comparable outcomes including mortality to high-dose methylprednisolone for the treatment of severe COVID-19.
by S Joshi 2024Low-dose methylprednisolone had comparable outcomes including mortality to high-dose methylprednisolone for the treatment of severe COVID-19.
by S Joshi 2024Low-dose methylprednisolone had comparable outcomes including mortality to high-dose methylprednisolone for the treatment of severe COVID-19.
by S Joshi 2024Low-dose methylprednisolone had comparable outcomes including mortality to high-dose methylprednisolone for the treatment of severe COVID-19.
methylprednisolone acetate equal to 7 times the daily oral dose of methylprednisolone once weekly. Does methylprednisolone help with COVID?
Comments